Inventor · disambiguated record
Martin Ian Cooper
Also filed as: COOPER MARTIN I · COOPER MARTIN IAN
10 granted patents·11 pending applications·41 citations·filing 2007–2019
87Inventor score
Files withCEPHALON INC8MILLENNIUM PHARM INC5DYNOGEN PHARMACEUTICALS INC2ARMITAGE IAN G1ARMITAGE Ian1
Top patents by PatentIndex Score
21 records- 0193US8669279B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2013·Granted Mar 11, 2014·17 cites·22 claims
- 0292US8883836B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2014·Granted Nov 11, 2014·12 cites·22 claims
- 0387US9533955B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2016·Granted Jan 3, 2017·4 cites·12 claims
- 0482US8653064B2Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin-2-yl]amino}-2-methoxybenzoateARMITAGE Ian·Filed 2011·Granted Feb 18, 2014·3 cites·20 claims
- 0574US2020323824A1Novel solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2019·Application pending·0 cites
- 0671US10301287B2Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylateTOBIRA THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·1 cites·44 claims
- 0770US10517852B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2018·Granted Dec 31, 2019·0 cites·1 claims
- 0870US9187482B2Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamateARMITAGE IAN G·Filed 2010·Granted Nov 17, 2015·3 cites·29 claims
- 0968US10016427B2Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-D]pyrimidin-7-YL}-2-hydroxycyclopentyl) methyl sulfamateMILLENNIUM PHARM INC·Filed 2015·Granted Jul 10, 2018·1 cites·23 claims
- 1068US2009264488A1Novel solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2009·Application pending·0 cites
- 1166US2015051258A1Novel Solid Forms Of Bendamustine HydrochlorideCEPHALON INC·Filed 2014·Application pending·0 cites
- 1265US10039750B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2016·Granted Aug 7, 2018·0 cites·8 claims
- 1363US2014357622A1Crystalline forms of sodium 4--2-methoxybenzoateMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 1458US10017513B2Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-D][2]benzazepin-2-YL]amino}-2-methoxybenzoateMILLENNIUM PHARM INC·Filed 2016·Granted Jul 10, 2018·0 cites·26 claims
- 1550US2015133460A1Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disordersMILLENNIUM PHAMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1650US2010273808A1Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disordersMILLENNIUM PHARMACETICALS INC·Filed 2009·Application pending·0 cites
- 1748US2007254899A1Soluble salts of thieno[2,3-d]pyrimidine derivativesDYNOGEN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1844US2007254891A1Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno[2,3-d]pyrimidineDYNOGEN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1942US2012202825A1Soluble Salts of Thieno [2,3-d] Pyrimidine DerivativesCOOPER MARTIN IAN·Filed 2011·Application pending·0 cites
- 2042US2009137579A1Mesylate salt of an IKK inhibitorMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 2140US2009131422A1Salts of an IKK inhibitorMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Ian Cooper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →